Press Releases

Global Health Leaders Back Aetion with $27 Million Strategic Investment

Aetion, a healthcare technology company that delivers the real-world analytics and evidence platform needed to engage in value-based care, announced that it has attracted strategic investment from global leaders in biopharma and healthcare services, including McKesson Ventures; Sanofi; UCB; and Horizon Health Services, Inc., a Blue Cross Blue Shield of New Jersey company. These companies join existing venture capital partners who also participated in this round. The $27 million funding round reflects Aetion’s substantial growth in customer adoption over the past year. Coupled with its prior...

University of Mississippi Medical Center (UMMC) to Utilize Kyruus Technology to Enhance Patient Access and Patient-Provider Matching

The University of Mississippi Medical Center (UMMC) has selected Kyruus’ ProviderMatch for Access Centers to power its call center and optimize patient access across Mississippi. UMMC’s partnership with Kyruus will help call centers identify the best provider for a patient’s needs. Currently, UMMC’s network includes 800+ providers at 170 locations, which serve over 600,000 patients per year statewide. Kyruus’ software will allow providers to better indicate their areas of expertise—down to specific conditions and procedures—and empower call center agents with that information. Implementation of Kyruus’ ProviderMatch for...

McKesson Ventures Donates $10,000 to Meals on Wheels America on Behalf of Landmark Health

Contribution marks the second donation McKesson Ventures has made in 2018 as part of its philanthropic commitment to portfolio companies and their missions SAN FRANCISCO – June 26, 2018 – McKesson Ventures, the venture capital arm of McKesson Corporation, today announced that it has donated $10,000 to Meals on Wheels America on behalf of its former portfolio company Landmark Health, a leading provider of in-home, risk-based medical care. As part of its deep commitment to supporting the growth and mission of its portfolio companies, McKesson Ventures...

Kyruus to Host Fifth Annual Thought Leadership on Access Symposium (ATLAS) in October 2018

Kyruus, a provider of search and scheduling solutions for health systems, will host the Fifth Annual Thought Leadership on Access Symposium. The symposium will take place from October 15-17, 2018, in Boston. During ATLAS, executives from patient access, patient experience, innovation, marketing, and clinical functions will discuss an array of timely topics around issues of patient access across the health system. This year’s theme, Systemness. Ignited, will focus on the role patient access plays in laying the foundation for positive, cohesive experiences. This year’s keynote speakers include...

Medidata Defines the Future of Life Sciences with Acquisition of SHYFT Analytics

Medidata announced on June 12 that it will acquire SHYFT Analytics for a total consideration of $195 million. The acquisition is subject to customary closing adjustments, is inclusive of Medidata’s prior 6% ownership in SHYFT’s business, and will be paid in cash. “Together, Medidata and SHYFT are powering customers’ digital transformation with artificial intelligence and real-world analytics to reduce risk, optimize revenue, and ultimately help patients,” said chairman and CEO of Medidata, Tarek Sherif. He continued, “Combining our innovative solutions, talented teams and shared values, across...

Pharmapacks Raises $32.5 Million to Fund Expansion, Automation and Talent Acquisition

Pharmapacks today announced that it has raised $32.5 million in a strategic round led by CPG company RB. Additional investments were made by McKesson Ventures, Sealed Air, and The Emerson Group. Pharmapacks also sold a minority stake as part of the round for an undisclosed amount. Pharmapacks is a leading e-commerce company that sells common consumer goods and helps emerging brands launch through its e-commerce platform and consumer base. The funding will be used to expand the Pharmapacks team and warehouse space, improve its automated technology,...

Propeller Health Raises Strategic Investment from McKesson Ventures

Propeller Health announced today that McKesson Ventures has contributed an undisclosed amount to its $20 million strategic funding round. The funding will allow Propeller Health to continue developing connected medicines for the treatment of chronic respiratory disease and expand into additional therapeutic areas. David Van Sickle, co-founder and CEO of Propeller Health commented on the impact of the investment on the company’s current and future initiatives. “We’ve accumulated the expertise, infrastructure and distribution network to put connected medicines in the hands of people around the world,”...

Kyruus Named 2018 MedTech Breakthrough Award Winner

Kyruus’ ProviderMatch for Consumers solution has been awarded the “Best Patient Scheduling Solution” award by MedTech Breakthrough. The MedTech Breakthrough Rewards are designed to “honor excellence and recognize the innovation, hard work and success” in a variety of health and medical technology categories. This year, the judging panel considered over 3,000 nominations from 12 different countries worldwide. “With advancements in medical and health technology that include developments in areas such as artificial intelligence, robotics and medical data analytics, the 2018 MedTech Breakthrough Awards program garnered an...

Avizia and VeeMed Partner to Enable Seamless, Powerful Telehealth Programs

Telehealth company Avizia recently announced a new partnership with VeeMed, a leading provider of physician services for telehealth. The partnership brings together Avizia’s telehealth platform and VeeMed’s provider services for high-acuity use cases including neurology, behavioral health, and intensive care. The partnership will offer flexible options to deliver high quality virtual care programs for healthcare organizations. Through the collaboration, Avizia will be able to offer a full suite of telehealth tools for remote virtual health consultants and specialists. Founder and CEO of Avizia Mike Baird spoke about...

GRAIL Announces Data from Prototype Blood Tests for Early Cancer Detection

Earlier this month, GRAIL, Inc., a life sciences company dedicated to finding early detection strategies for cancer patients, announced that it has made progress toward developing a method for identifying multiple types of cancer through blood tests. The announcement was made at the annual American Association for Cancer Research meeting. Testing patients already known to have early stage cancer, GRAIL scientists employed full genome sequencing to analyze DNA entering the blood stream shed by dying tumor cells. Sixty-five percent of patients’ test results came back positive;...